1. 641569-94-0
2. 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic Acid
3. 4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoic Acid
4. 4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzoic Acid
5. Tq9wcs4pf0
6. Benzoic Acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
7. 4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzoic Acid
8. Mfcd11521324
9. 4-methyl-3-((4-(3-pyridyl)pyrimidin-2-yl)amino)benzoic Acid
10. 4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzoic Acid
11. Benzoic Acid, 4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-
12. 4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoic Acid
13. Unii-tq9wcs4pf0
14. Schembl533540
15. Dtxsid90439380
16. Ldlzphlsvkgfsc-uhfffaoysa-n
17. 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoicacid
18. Bcp04528
19. Akos015888621
20. Ac-8510
21. Ps-7101
22. Sb57892
23. A8804
24. Am20090654
25. Cs-0009198
26. Ft-0655847
27. 4-(5-amino-6-hydroxy-2-benzoxazolyl)-benzoicacid
28. Nilotinib Hydrochloride Monohydrate Impurity D [ep]
29. Q-101350
30. 4-methyl-3-(4-(pyridine-3-yl)pyrimidin-2-ylamino)benzoic Acid
31. 4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzoic Acid
32. 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzoic Acid
33. Nilotinib Hydrochloride Monohydrate Impurity D [ep Impurity]
34. 4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)benzoic Acid;4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic Acid
35. Benzoic Acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-; 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic Acid; Nilotinib Hydrochloride Monohydrate Impurity D; Nilotinib Impurity D
| Molecular Weight | 306.32 g/mol |
|---|---|
| Molecular Formula | C17H14N4O2 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 88 |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 406 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
SUPPLIERS
4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl] Amino]...
CAS Number : CAS-641569-94-0
End Use API :
End Use API : Nilotinib
About the Company : We are Rampex Labs, a fully cGMP compliant pharmaceutical intermediates plant located in the outskirts of Hyderabad, India. Our company was founded in 2004 with commercial operations st...
4-methyl-3-[(4-pyridin-3-ylpyrimidin-2- yl)amino]b...
CAS Number : 641569-94-0
End Use API :
End Use API : Nilotinib
About the Company : Haorui, established in 1997, is a manufacturer and supplier of APIs, intermediates, veterinary and food additives. Meanwhile, it is assisting global pharmaceutical companies to get the ...
4-Methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}...
CAS Number : 641569-94-0
End Use API :
End Use API : Nilotinib
About the Company : Tivan Sciences is an API manufacturing company founded in January 2020 and located in Rajkot, Gujarat. The company is committed to developing high-quality products through robust in-hou...
END USE APIs
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
RELATED INTERMEDIATES
LOOKING FOR A SUPPLIER?
